Implandata Ophthalmic Products raises €1.4M Series A round
30 January 2012· Hannover, Germany· health, biotech, ai, b2b, software_hardware
The funding was raised to support the CE approval process, carry out initial implantations, and prepare for market entry for the EYEMATE system.
Investors
LeadHannover Beteiligungsfonds
Also participating
High-Tech Gründerfonds
About Implandata Ophthalmic Products
Stage
Series B
Headquarters
Hannover, Germany
Founded
2010
Team Size
6–20
Sectors
healthbiotechaib2bsoftware_hardware
Source: https://www.finsmes.com/2012/01/implandata-ophthalmic-products-raises-e1-4m-series-financing.html